Genome & Company Market Cap

Genome & Company has a market cap or net worth of 312.64 billion as of March 20, 2026. Its market cap has increased by 246.21% in one year.

Market Cap

312.64B

Enterprise Value

301.77B

Revenue

25.95B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,460.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 312.64B, an increase of 334.96%. That is a compound annual growth rate of 22.53%.

Market Cap History

Date	Market Cap	% Change
Mar 20, 2026	312.64B	31.15%
Dec 30, 2025	238.38B	179.77%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 26, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
S.Biomedics	418.00B
curacle co.,ltd.	390.29B
NIBEC	344.96B
Bio Solution	301.19B
ABION	259.94B
TiumBio	252.40B
Kangstem Biotech	250.65B
Ensol Biosciences	207.51B

Market Cap Rankings